Patient involvement in prostate cancer treatment decisions

Completed

• Conditions: Prostate cancer; Cancer

• Registration Number: ISRCTN97145188
• Lead Sponsor: Dutch Cancer Society (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09-12
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 300

Inclusion Criteria

Patients with prostate cancer referred for radiotherapy with curative intent are eligible.

Exclusion Criteria

Labile personality structure, as assessed by the physicians, and lack of understanding of the Dutch language.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome measure is choice acceptance. At the end of the interview, the patient is asked whether he wants to choose one of the two treatment options, or whether he wants to leave the decision to the physician. The response to this question is choice acceptance. Choice acceptance is confirmed by telephone 2 days later. This measure is obtained about 10 days after the first consultation.

Secondary Outcome Measures

Name	Time	Method
1. Substitute preferences of physicians <br>2. Quality of life measures<br>3. Decision evaluation measures <br>4. Coping measures<br>5. Knowledge measures <br>6. Treatment preferences